The Indian Pharma Industry is moving towards a biosimilars manufacturing growth phase. Earlier this year, India was the subject of a global collaboration that reflects growing international trust in its abilities
The Alzheimer's drug market is witnessing a significant strategic shift as Eisai and Biogen strengthen their competitive position. AS the new FDA approval allows at-home initiation of their therapy
Emcure has tightened its grip on Gennova with a Rs 231.8 crore acquisition. The deal will make Gennova a wholly owned subsidiary of the company.
A major breakthrough in the treatment of advanced rectal cancer has emerged as innovative immunotherapy drugs continue to reshape oncology
The Oxford Ebola vaccine has reached a major milestone. The University of Oxford has started the world's first human trial for a vaccine against the Bundibugyo Ebola virus.
India's Breast Cancer Survival Rate is improving, offering hope to thousands of women. However, the country still trails many high-income nations. A new World Health Organization (WHO) report shows that India's five-year survival rate has reached...
Artificial intelligence is rapidly transforming the Indian pharmaceutical landscape, enabling faster, more accurate, and cost-efficient drug development processes
Differentiated products in India are gaining strong momentum as pharmaceutical companies are increasingly focusing on innovation-led drug development to meet medical needs
With the emergence of new risks in the routine and complex surgical procedures, the threat of antibiotic resistance is increasingly attracting public awareness
Mankind Pharma has approved two major strategic decisions to sharpen its long-term growth strategy. The company will sell its hospitality business for Rs49 crore.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")